相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
Gustavo Ferrin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Impact of Everolimus-based Immunosuppression on Renal Function in Liver Transplant Recipients
Flor Nogueras Lopez et al.
TRANSPLANTATION PROCEEDINGS (2020)
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria
Takuya Sho et al.
HEPATOLOGY RESEARCH (2020)
microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis
Eun Byul Lee et al.
VIRUSES-BASEL (2020)
Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry
Faouzi Saliba et al.
LIVER TRANSPLANTATION (2020)
Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
Kwang-Woong Lee et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Autophagy and liver cancer
Xiaojuan Chao et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Long-term prognosis and management of hepatocellular carcinoma after curative treatment
Naoshi Nishida
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Systematic review with meta-analysis: sirolimus-or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
Sam E. Grigg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response
Keungmo Yang et al.
HPB (2019)
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years
Faouzi Saliba et al.
LIVER TRANSPLANTATION (2019)
Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study
Long-Bin Jeng et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
Dong-Hwan Jung et al.
LIVER TRANSPLANTATION (2018)
Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications
Pil Soo Sung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Fatigue and weakness hinder patient social reintegration after liver transplantation
So Hyun Kang et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial
F. Saliba et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: A systematic review and meta-analysis
Michael Lin et al.
CLINICAL TRANSPLANTATION (2017)
Effects of Maintenance Immunosuppression With Sirolimus After Liver Transplant for Hepatocellular Carcinoma
Elizabeth L. Yanik et al.
LIVER TRANSPLANTATION (2016)
Use of everolimus in liver transplantation: The French experience
Jerome Dumortier et al.
TRANSPLANTATION REVIEWS (2016)
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
Itxarone Bilbao et al.
LIVER TRANSPLANTATION (2015)
Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation
Gun Hyung Na et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
P. De Simone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Surgical Outcome of Right Liver Donors in Living Donor Liver Transplantation: Single-Center Experience with 500 Cases
Say-June Kim et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Conversion to Everolimus in Maintenance Liver Transplant Patients: A Multicenter, Retrospective Analysis
Faouzi Saliba et al.
LIVER TRANSPLANTATION (2011)
Conversion from a Calcineurin Inhibitor to Everolimus Therapy in Maintenance Liver Transplant Recipients: A Prospective, Randomized, Multicenter Trial
Paolo De Simone et al.
LIVER TRANSPLANTATION (2009)
分享论文
